This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

eBriefing

Neuro-Immunology and Alzheimer’s Disease: Exploring Therapeutic Approaches

Neuro-Immunology and Alzheimer’s Disease
Reported by
Kristifor Sunderic

Posted January 18, 2019

Kristifor Sunderic is an NYC based freelance science writer interested in the intersection of biotechnology and society.

Presented By

Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

Overview

Alzheimer’s disease (AD) is a devastating neurodegenerative disorder for which there is a major unmet therapeutic need.  Limited success from current translational models and amyloid-centric clinical trials highlight the need for broader therapeutic strategies.  As a result, researchers are closely examining interactions between the brain and the immune system to understand how innate immune processes affect the pathology of Alzheimer’s disease. On September 25, 2018, the New York Academy of Sciences hosted Neuro-Immunology: The Impact of Immune Function on Alzheimer’s Disease, a symposium that brought together experts working at the intersection of neurology and immunology, with the goal of targeting the immune system for next-generation Alzheimer’s disease therapeutics.

Speakers

Phillip De Jager, MD, PhD
Phillip De Jager, MD, PhD

Columbia University Irving Medical Center

Anne Schaefer, MD, PhD
Anne Schaefer, MD, PhD

Icahn School of Medicine at Mount Sinai

Marta Olah
Marta Olah, PhD

Columbia University Irving Medical Center

Elizabeth Bradshaw, PhD
Elizabeth Bradshaw, PhD

Columbia University Irving Medical Center

Linda Van Eldik, PhD
Linda Van Eldik, PhD

University of Kentucky

Malú Tansey, PhD
Malú Tansey, PhD

Emory University School of Medicine

Frederic Geissmann, MD, PhD
Frederic Geissmann, MD, PhD

Memorial Sloan Kettering Cancer Center

Jie Shen, PhD
Jie Shen, PhD

Harvard Medical School

Bruce Lamb, PhD
Bruce Lamb, PhD

Indiana University School of Medicine

Catherine Kaczorowski, PhD
Catherine Kaczorowski, PhD

The Jackson Laboratory

Keynote Address
Session 1: From Genes to Mechanism — Immune Cells in Alzheimer’s Disease
Session 3: Targeting the Immune System in Neurodegenerative Disease
Session 4: Developing New Models from Human Disease Signatures